Glenmark Pharmaceuticals unlocks the treatment for mild to moderate Covid-19 in India June 21, 2020 MUMBAI: In a landmark development for COVID-19 patients in India, Glenmark Pharmaceuticals announced the launch of antiviral drug Favipiravir (brand name FabiFlu) for the…
Glenmark gets regulator’s approval to try Favipiravir on COVID-19 patients in India April 30, 2020 MUMBAI: Glenmark Pharmaceuticals, a research-led pharmaceutical company, announced that it has received approval from the DCGI (Drug Controller General of India), the regulator in…
Hikma and Glenmark sign agreement to commercialise Ryaltris February 27, 2020 LONDON: Hikma Pharmaceuticals and Glenmark Specialty, a Swiss subsidiary of Glenmark Pharmaceuticals, announced the signing of an exclusive US license agreement to commercialise Ryaltris…
Glenmark Pharmaceuticals receives ANDA approval for Clobetasol Propionate Foam September 10, 2019 MUMBAI, INDIA: Glenmark Pharmaceuticals Inc., USA has been granted final approval by the United States Food & Drug Administration (U.S. FDA) for Clobetasol Propionate…